Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE
Systemic Lupus Erythematosus
About this trial
This is an interventional health services research trial for Systemic Lupus Erythematosus focused on measuring Lupus, Quality of life, Multicomponent intervention, Clinical Practice Guideline, Computerized clinical decision support system, Activity
Eligibility Criteria
Inclusion Criteria:
- Patients:
Adults (older than 18 years) diagnosed with SLE of any seriousness and situation (active, remission or clinically quiescent and serologically active), who agree to participate and sign informed consent.
- Health professionals:
Physicians specialized in rheumatology or internal medicine that include in their quotas a minimum of 30 patients with eligible SLE.
Exclusion Criteria:
- Patients:
SLE limited to the skin, advanced chronic kidney disease (dialysis or renal transplant); Mental illnesses and / or sensory or cognitive deficits; or participating in extension or follow-up studies of another RCT (possible change in follow-up guidelines). Participants in observational studies may be included as they do not change usual practice.
Sites / Locations
- Servicio de Evaluación del Servicio Canario de la Salud
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Multicomponent Intervention
Control
Rheumatologist and internist receive a multicomponent intervention
Rheumatologist and internist provide the usual care